Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Show others and affiliations
2012 (English)In: Cancer Cell International, ISSN 1475-2867, E-ISSN 1475-2867, Vol. 12, 17- p.Article in journal (Refereed) Published
Abstract [en]

Background: Paralemmin-1 is a phosphoprotein lipid-anchored to the cytoplasmic face of membranes where it functions in membrane dynamics, maintenance of cell shape, and process formation. Expression of paralemmin-1 and its major splice variant (Delta exon 8) as well as the extent of posttranslational modifications are tissue-and development-specific. Paralemmin-1 expression in normal breast and breast cancer tissue has not been described previously. Results: Paralemmin-1 mRNA and protein expression was evaluated in ten breast cell lines, 26 primary tumors, and 10 reduction mammoplasty (RM) tissues using real time RT-PCR. Paralemmin-1 splice variants were assessed in tumor and RM tissues using a series of primers and RT-PCR. Paralemmin-1 protein expression was examined in cell lines using Western Blots and in 31 ductal carcinomas in situ, 65 infiltrating ductal carcinomas, and 40 RM tissues using immunohistochemistry. Paralemmin-1 mRNA levels were higher in breast cancers than in RM tissue and estrogen receptor (ER)-positive tumors had higher transcript levels than ER-negative tumors. The Delta exon 8 splice variant was detected more frequently in tumor than in RM tissues. Protein expression was consistent with mRNA results showing higher paralemmin-1 expression in ER-positive tumors. Conclusions: The differential expression of paralemmin-1 in a subset of breast cancers suggests the existence of variation in membrane dynamics that may be exploited to improve diagnosis or provide a therapeutic target.

Place, publisher, year, edition, pages
2012. Vol. 12, 17- p.
Keyword [en]
Paralemmin-1, Breast cancer, PALM, Estrogen receptor, Tissue microarrays, Splice variants
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-188574DOI: 10.1186/1475-2867-12-17ISI: 000311333000001OAI: oai:DiVA.org:uu-188574DiVA: diva2:578435
Available from: 2012-12-18 Created: 2012-12-17 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

fulltext(1902 kB)96 downloads
File information
File name FULLTEXT01.pdfFile size 1902 kBChecksum SHA-512
8fa3d44eab6e808526a86d744b77d476cbbcfda3a429416e7156f1e9939992f10d9a221e15fbbbe5a5e977f7b46ff7e61480958d0b7fa681de6d5ca13dc9ee91
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Kilimann, Manfred W.

Search in DiVA

By author/editor
Kilimann, Manfred W.
By organisation
Molecular Cell Biology
In the same journal
Cancer Cell International
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 96 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 445 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf